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Background: In the UK around 22% of men and 24% of women are obese, and there are varying but worrying
levels in other European countries. Obesity is a chronic condition that carries an important health risk. National
guidelines, for use in England, on the management of people who are overweight or obese have been published
by the National Institute for Health and Clinical Excellence (NICE, 2006). NICE recommendations for primary care
teams are: determine the degree of overweight and obesity; assess lifestyle, comorbidities and willingness to
change; offer multicomponent management of overweight and obesity; referral to external services when
appropriate. This study investigates a tailored intervention to improve the implementation of these
recommendations by primary care teams.
Methods/Design: The study is a cluster randomised controlled trial. Primary care teams will be recruited from the
East Midlands of England, and randomised into two study arms: 1) the study group, in which primary care teams
are offered a set of tailored interventions to help implement the NICE guidelines for overweight and obesity; or 2)
the control group in which primary care teams continue to practice usual care. The primary outcome is the
proportion of overweight or obese patients for whom the primary care team adheres to the NICE guidelines.
Secondary outcomes include the proportion of patients with a record of lifestyle assessment, referral to external
weight loss services, the proportion of obese patients who lose weight during the intervention period, and the
mean weight change over the same period.
Discussion: Although often recommended, the methods of tailoring implementation interventions to account for
the determinants of practice are not well developed. This study is part of a programme of studies seeking to
develop the methods of tailored implementation.
Trial registration: Current Controlled Trials ISRCTN07457585. Registered 09/08/2013. Randomisation commenced
30/08/2013.
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Table 1 The NICE recommendations for the treatment of
overweight and obesity
Recommendation
1 Determining degree of
overweight and overweight
• Use clinical judgement to decide
when to measure weight and height
• Use body mass index to classify the
degree of overweight or obesity
• Use waist circumference in people
with a body mass index less than
35 kg/m2 to assess health risks
• To tell the patient their classification,
and how this affects their risk of long-
term health problems
2 Assessment of lifestyle and
willingness to change
• Presenting symptoms and underlying
causes of overweight or obesity
• Risk factors and comorbidities
• Eating behaviour, diet and physical
activity
• Willingness and motivation to change
3 Management of overweight
and obesity
• Increased physical activity
• Improved eating behaviour
• Healthy eating
• If appropriate, drug treatment
4 Referral • For assessment of the underlying
cause of overweight or obesity
• If conventional treatment has failed
• If specialist interventions may be
needed
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Obesity
National guidelines, for use in England, on the manage-
ment of people who are overweight or obese have been
published by the National Institute for Health and Clin-
ical Excellence (NICE) [1]. In the guidelines, overweight
is defined as body mass index (BMI) of between 25 and
30 kg/m2 and obesity is defined as a BMI of 30 kg/m2 or
over. In 2011, 65% of adult men in England were classi-
fied as overweight with 24% obese, with similar percent-
ages among women (58% and 26% respectively) [2]. The
prevalence of obesity varies by level of social deprivation,
and reaches 33% in women in the lowest socio-
economic group [3]. High though these levels of obesity
may be, it has been predicted on the basis of current
trends that they will have risen even further by 2030 [4].
Obesity is a chronic condition that confers an import-
ant health risk [5]. It has been estimated that the effects
of obesity exceed those of smoking or excess alcohol [6].
It is associated with increased rates of mortality, dia-
betes, coronary heart disease, hypertension, osteoarth-
ritis and some cancers, and leads to increased health
care costs [7]. It also reduces health-related quality of
life and increases time lost from work [4,8].
In 2011, the government in England launched a strat-
egy intended to reduce levels of obesity by 2020 includ-
ing plans to improve food labelling and encourage more
healthy lifestyles [9]. Health services also have responsi-
bilities in reducing the number of people who are over-
weight and obese, and excess weight in both adults and
children has been included among the new outcome in-
dicators for the English health service [10].
In England, primary care services are important in
identifying people who are obese, or at risk of becoming
obese, and offering advice, support, and practical inter-
ventions. Some people may be referred to receive dietary
and exercise advice, or for consideration of bariatric sur-
gery. Patients may also opt to attend weight reduction
services that charge a fee, for example Weight Watchers
or Slimming World [11,12]. NICE identifies a range of
barriers to following the guidelines, including percep-
tions among patients, social pressures including market-
ing of foods, and poor access to weight reduction
services, including exercise facilities. The most com-
monly reported barriers to effective management of
obesity in the primary care setting include: psychological
complexities of cases, high rate of relapse, perceived lack
of effective interventions, lack of time, lack of resources,
and lack of onward referral options [13]. In pilot work in
Leicester, UK, we have identified a sense of helplessness
among health professionals as a potential barrier [14]. A
2010 review of strategies to promote weight reduction in
obese patients through changing the behaviour of health
professionals and the organisation of care by Flodgrenand colleagues [15] has identified the need for better de-
veloped and evaluated interventions to achieve effective
weight reduction advice by health care professionals.
Targets for improvement
This study is part of the Tailored Implementation for
Chronic Diseases (TICD) project, which has the overall aim
of developing and testing methods of tailoring implementa-
tion interventions to determinants of practice for know-
ledge in chronic illness care [16]. In the TICD project, we
developed a programme for implementing the NICE obes-
ity guidelines in a stepwise approach. The first step involved
identifying from the NICE guidelines those recommenda-
tions applicable to primary care, and which would be se-
lected for implementation (see Table 1) [1].
Health system context
England has a national health service that provides free
access to care, and is funded from taxation. However,
there are charges for a limited range of services, includ-
ing dental care, and patients aged under 60 are required
to a pay fixed charge for prescription medicines. Follow-
ing organisational reforms in 2013, public health services
are managed through local authorities or councils. Hos-
pitals provide inpatient and outpatient care, and primary
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Around 98% of the population is registered with a gen-
eral practice, practices having registered lists of patients,
electronic record systems, and multidisciplinary primary
care teams that include doctors, nurses, and health care
assistants [17]. Practices are paid through a combination
of capitation and pay for performance schemes, notably
the quality and outcomes framework (QOF) and pay-
ments for enhanced services. Practices vary widely in
size, although the mean size is approximately 6,800 pa-
tients [17]. In 2012, there were 8,088 general practices in
England, 921 of which were classified as single-handed.
There were 35,871 full time equivalent general practi-
tioners (GPs), 14,695 full time equivalent practice
nurses, and 70,851 full time equivalent practice staff in
other categories. The total number of patients registered
with GPs in England was 55.7 million (patients are re-
quired to register with a single practice in order to re-
ceive primary care).
Usual care
There is an indicator for obesity in the QOF as follows:
the contractor establishes and maintains a register of pa-
tients aged 16 or over with a BMI ≥30 in the preceding
12 months, and therefore practices have some financial
incentive for the detection of obesity [18]. Yet despite
this, the proportion of the population recorded on gen-
eral practice obesity registers falls well short of the pro-
portion identified as obese in systematic population
surveys, nationally being only 10.7% in 2012 [19] com-
pared with approximately 20% in population surveys.
Failure to record obesity is not the only performance def-
icit. An implementation uptake report on the surgical and
pharmacological interventions for obesity found that the
NICE clinical guidelines had mixed impact in practice [1].
Prescription patterns were in line with the NICE guidance
but the low proportion of patients receiving advice prior to
the start of their drug treatment indicated deviance from
the guidance. Lack of adherence to the NICE clinical guide-
lines for obesity was also reported by the Office of Health
Economics [20]. The Office of Health Economics, which
administered questionnaires to the 151 Primary Care Trusts
that managed primary care teams in England at the time of
the survey to assess their views on the degree of similarity
between their local referral process/guidelines for obesity
and the NICE guidance. People with obesity, therefore, may
well not be identified and recorded in general practice, and,
even if they are, support and management may not be in
accordance with the guidelines. Yet, with around a quarter
of the UK population being obese [17], the effective imple-
mentation of the NICE clinical guidance on obesity has po-
tential to benefit individual and population health and
reduce the economic burden of the health consequences of
obesity [1].The Tailored Implementation for Chronic Diseases project
The underlying conceptual framework to TICD is that im-
plementation is more likely to be effective when the deter-
minants of practice have been identified and a strategy
(that may include several discrete interventions) is designed
and delivered to address them. This process is referred to
as tailored implementation.
Our Cochrane review [21] has shown that this approach
can be effective, but as yet the most appropriate methods
used to identify determinants and tailor a strategy to ac-
count for them have not been determined. In the review,
twelve studies provided sufficient information to be in-
cluded in the quantitative analysis, and a pooled odds ratio
of the effectiveness of tailored interventions was 1.54 (95%
confidence interval 1.16 to 2.01). TICD sets out to advance
the methodology of tailored implementation.
The first component study of TICD, a review of determi-
nants and development of a checklist that can assist in
identifying them in implementation initiatives, has been
completed and published [22]. A second study has com-
pared various methods for investigating determinants; for
example, interviews of professionals or patients, or brain-
storming (manuscript in preparation). A third study has in-
vestigated the methods that can be used to plan the
implementation strategy taking account of the determi-
nants of practice (manuscript in preparation). Both the sec-
ond and third studies have been completed, and have laid
the foundation for the trial described in this protocol.
Objectives
The primary aim of the study is to examine the effective-
ness of a tailored implementation strategy in comparison
with usual care for improving adherence to the NICE
guidelines for the management of overweight and obes-
ity in primary care teams.
The secondary aim is to examine the extent to which the
most important determinants were identified and appropri-
ate interventions used to address them, which we refer to
as the validity of methods. A process evaluation will be
undertaken to investigate how successful the tailoring
process was in identifying and addressing determinants, the
fidelity of intervention delivery, and how the study partici-
pants responded to the intervention.
Research questions
1. What is the effectiveness of a tailored
implementation programme compared to no
intervention (usual care) in improving adherence of
primary care teams to the NICE guidelines on
overweight and obesity?
2. What is the validity of the methods used to tailor
the implementation programme to determinants of
practice?
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Trial design
This study is a cluster randomised trial in primary care
[23,24] that will randomise general practices into two
study arms: 1) the study group in which primary care
teams are offered a set of tailored interventions; or 2)
the control group in which primary care teams adminis-
ter usual care.
Participants and setting
All general practices in the East Midlands of England will
be invited to participate in the study. The area includes
the following Clinical Commissioning Groups (CCGs):
Leicester City CCG, East Leicester & Rutland CCG, West
Leicestershire CCG, NHS Southern Derbyshire CCG,
North Derbyshire CCG, NHS Lincolnshire East CCG,
Lincolnshire West CCG, North East Lincolnshire
CCG, North Lincolnshire CCG, Mansfield and Ashfield
CCG, Nottingham North & East CCG, Nottingham West
CCG, Rushcliffe CCG, NHS Nottingham City CCG,
Newark & Sherwood CCG, NHS Corby CCG, Nene CCG.
This is an area of approximately 3.5 million inhabitants,
served by 630 general practices. Further information on the
demographic and disease prevalence within the CCGs is
shown in Table 2. The population is typical of England for
social status and age distribution, but with a slightly higher
proportion of non-white ethnicity. There are three to four
large urban centres, but also small towns and more isolated
rural communities. Levels of obesity are around the na-
tional average (25%), and obesity is a key regional health
priority [25]. In recruiting primary care teams, we will work
with the East Midlands Primary Care Research Network.
Patients
Eligible patients are adults aged 16 years and over in the
participating practices who are either overweight or
obese, whether or not they are recorded in the practice
obesity register. Patients will not be randomised or dir-
ectly involved in the study, although anonymised data
will be extracted from their electronic medical records.
Overweight is defined as a BMI of between 25 and
30 kg/m2 and obesity is defined as a BMI of over 30 kg/
m2 [1].
Implementation programme
Development of the implementation programme
In previous phases of the TICD project (reported in detail
elsewhere [16]), determinants for the implementation of
the targeted recommendations have been identified as well
as strategies for identifying those determinants. Samples of
implementation experts, health professionals and patients
were involved in a variety of methods to collect information
on determinants (brainstorming, structured group dis-
cussion, interviews and questionnaires). The identifieddeterminants were assessed for their importance in deter-
mining practice (important determinants were those that
had a large impact on practice), and were capable of being
addressed (it was plausible that the determinant could be
addressed to improve clinical practice). Those determinants
judged plausibly important were then subjected to a sys-
tematic process for selecting interventions. New samples
of implementation experts, professionals and patients
were involved in group meetings, and asked to propose
interventions that would be likely to address the deter-
minants (see Table 2). On the basis of this prior work a
tailored implementation programme has been developed,
in which each intervention addresses one or more specific
determinants. These are outlined in Table 3.
Delivering the interventions will involve visits to prac-
tices and interaction with the primary care teams (GPs
and practice nurses). The interventions will be delivered
to as many members of the primary care team as possible.
We will also ask for one member of the team (usually a
practice nurse) to take the lead on the improvement of
overweight and obesity care within their team. We will
work with the identified person to improve their know-
ledge and resources to effectively manage the care of their
overweight and obese patients (Figure 1).
Logic model
The interventions (which aim to address the determi-
nants listed in Table 3) will include a practice-based,
interactive session which will be delivered to as many
members of the recruited primary care teams as possible
(Figure 2). The session will provide teams with a re-
minder of the NICE guidelines for overweight and obes-
ity, and with practical tips and suggestions for their
implementation within their clinical practice. The ses-
sion will be delivered primarily as a presentation plus
interactive discussion focused around each of the four
NICE recommendations and tailored to address the de-
terminants identified in study 2.
We will also offer the study teams repeat visits,
monthly telephone calls with the obesity lead, and a
closed list of contacts to enable them to establish a sup-
port network with other study group teams.
The recommendations
The implementation programme will address the deter-
minants relating to each of the four targeted guideline
recommendations.
Recommendation 1: Determining the degree of over-
weight and obesity Determinants addressed:
 Acceptable ways to raise and discuss the issue of
weight with patients
 How to effectively measure waist circumference
Table 2 Demographic and disease prevalence within Clinical Commissioning Groups [26,27]
Clinical Commissioning
Group (CCG)
Average index of
multiple deprivation
IMD 2010 score
Population density
(persons per hectare)
Population from
black ethnic groups
Population from
Asian ethnic groups
Disease prevalence (number and percentages); that is,
patients on general practice quality and outcomes
framework registers with these conditions
Obesity Coronary
heart disease
Diabetes
mellitus
Corby CCG 26.49 7.6 1.6% 1.3% 4,869 (11.9%) 1,732 (3.4%) 2,119 (5.2%)
East Leicester and Rutland CCG 9.96 2.0 0.7% 7.2% 24,258 (9.4%) 10,786 (3.4%) 13,555 (5.3%)
Leicester City CCG 33.68 45.0 6.2% 37.1% 28,405 (9.8%) 10,018 (2.7%) 19,959 (7.0%)
Lincolnshire West CCG 19.29 1.9 0.5% 1.3% 22,375 (12.2%) 9,163 (4.1%) 10,219 (5.7%)
Lincolnshire East CCG 24.14 0.9 0.3% 0.8% 12,675 (5.3%) 24,711 (12.2%) 14,784 (7.4%)
Mansfield and Ashfield CCG 29.32 11.3 0.4% 1.1% 21,473 (14.3%) 7,887 (4.3%) 8,714 (5.9%)
Nene CCG 16.92 3.1 2.6% 4.0% 50,416 (10.1%) 18,977 (3.1%) 26,742 (5.4%)
Newark & Sherwood CCG 19.05 1.8 0.3% 0.9% 13,354 (12.7%) 5,168 (4.1%) 5,563 (5.4%)
North Derbyshire CCG 17.84 2.4 0.4% 1.0% 26,401 (11.0%) 12,345 (4.3%) 14,307 (6.0%)
North East Lincolnshire CCG 29.77 8.3 0.3% 1.3% 17,943 (13.2%) 7,101 (4.3%) 8,227 (6.2%)
North Lincolnshire CCG 22.21 2.0 0.3% 2.7% 18,424 (13.4%) 7,681 (4.6%) 8,582 (6.3%)
Nottingham City CCG 35.48 41.0 7.3% 13.1% 27,070 (9.7%) 9,675 (2.8%) 13,328 (4.9%)
Nottingham North & East CCG 17.46 9.3 1.3% 2.5% 6,741 (5.8%) 5,635 (3.9%) 13,039 (11.0%)
Nottingham West CCG 14.41 13.7 0.9% 4.1% 8,271 (10.7%) 3,826 (4.1%) 4,178 (5.5%)
Rushcliffe CCG 7.62 2.7 0.6% 4.2% 8,489 (8.5%) 4,375 (3.6%) 4,373 (4.4%)
Southern Derbyshire CCG 19.96 4.7 1.6% 6.8% 47,205 (11.1%) 18,745 (3.6%) 26,086 (6.2%)
West Leicestershire 13.09 4.2 0.5% 4.9% 29,878 (9.9%) 11,790 (3.2%) 16,329 (5.5%)
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Table 3 Interventions that address determinants
Recommendation Determinants Interventions
1 Determining degree of overweight
and overweight
Acceptable ways to raise and discuss the
issue with patients
Training and model scripts on discussing weight
with patients
How to effectively measure waist
circumference
Training in waist measurement
2 Assessment of lifestyle and willingness
to change
Ways to assess willingness to change Training
Resources to motivate and inform Booklet for patients
3 Management of overweight and
obesity
Lack of prescriptive information Training and booklet
Lack of knowledge Discussion with practices on delegation and the role
for practice nurses
4 Referral Lack of information on referral pathways Provision of information on local referral pathways
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and, if not raised sensitively, patients can be resistant
to discuss their weight or follow a proposed weight
loss intervention. Study 2 confirmed that health care
professionals found it difficult to find acceptable
ways to raise the issue of weight with patients. The
intervention aims to address this by providing scripts
for health care professionals to use in raising and
discussing weight with patients that are likely to be
acceptable to patients. We also aim to show video
clips of good and bad ways to raise weight with
patients.
To classify the degree of overweight and obesity, the
NICE guidelines recommend that waist circumference isFigure 1 An outline of the logic model of the intervention. We aim to
each practice – and to classify practices according to their resources and a
per general practitioner; b) engagement with the intervention – scaling an
identify what practices did as a result of the intervention and why – measumeasured in patients with a BMI less than 35 kg/m2 to
assess health risks. Study 2 identified that health care
professionals were unsure how to reliably measure waist
circumference and how waist circumference relates to
health risks. The intervention aims to address this by
providing information on how to effectively measure
waist circumference. A live demonstration will be pro-
vided in the practices and a thorough explanation relat-
ing waist circumference and increased health risks will
be provided. In addition health care professionals will
also be provided with posters (containing information
on how to measure waist circumference) which can be
placed in clinic rooms to provide a visual guide for them
to follow while measuring waist circumference.measure the following determinants of change: a) the capacity of
bility to implement an intervention, the average number of patients
d recording (measured by observations and example patients); and c)
red by interviewing one or two members of the practice.
Follow up: 9 months
01/10/2013–01/07/2013
Figure 2 A flow diagram and timescale of the study.
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willingness to change Determinants addressed:
 Ways to assess willingness to change
 Resources to motivate and inform patients
In order for a weight loss intervention to be successful
the patient needs to be ready and willing to make changes
to their lifestyle. If the patient is not ready and willing to do
so, it is likely the intervention will fail. The NICE guidelines
recommend that health care professionals assess a patient’s
lifestyle, co-morbidities and willingness to change. This can
be difficult to assess in a short consultation. The interven-
tion will explain how to assess whether a patient is ready to
make changes to their lifestyle. Health care professionals will
also be provided with questionnaires to assess motivation
and that can be used as a discussion point with patients.
The intervention will also provide health care profes-
sionals with resources that can be used to increase a
patient’s motivation, and suggest appropriate times to
use them within the consultation. The resources will
demonstrate the benefit of a modest weight loss (5 or
10% of body weight) for the patient.
Recommendation 3: Management of overweight and
obesity Determinants addressed:
 Lack of prescriptive information
 Lack of knowledgeMany patients interviewed during our investigation of
determinants felt that they were aware of the concept of
healthy eating, and the need to reduce their calorie in-
take to lose weight, but they felt more prescriptive ad-
vice would be of benefit. They felt that the advice
provided by commercial slimming clubs on portion sizes
and guidance on a more prescriptive diet would be bene-
ficial. The intervention will provide health care profes-
sionals with a prescriptive weight loss plan that can be
delivered to patients within primary care. The ‘Weight
loss you can see’ information booklet provides patients
with visible pictures of portion sizes for every day foods.
The booklet provides patients with a prescriptive energy
deficit diet. The energy level prescribed for a patient will
be based on an estimate of their initial maintenance en-
ergy needs minus 600 kcal/day [1]. Health care profes-
sionals will be provided with training to calculate energy
requirements, and the required portions of carbohy-
drates, vegetable, protein and dairy foods [28].
Health care professionals felt that they did not always
have sufficient knowledge or skill to advise patients on
changes to their diet. The intervention will also provide
health care professionals with a summary of the NICE
guidelines for diet and exercise.
Recommendation 4: Referral
Determinants addressed:
 Lack of information on referral pathways
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tives in primary care to improve health and assist weight
loss. Some of these programmes are available for patients
to self-refer into, while others require a referral from a
health care professional. Our investigation of determinants
found that many health care professionals were not aware
of the services on offer and how to refer patients to them.
The intervention aims to provide health care professionals
with an up to date list of the current services offered locally.
In addition clear guidance on the referral pathway to local
secondary services will also be given.
We will also ask each primary care team to designate a
health care professional for their team to lead their man-
agement of overweight and obesity. We will speak with the
local lead prior to delivering the intervention to identify
their current treatment plan for overweight and obesity to
identify any areas where the intervention may need to be
further tailored to meet the needs of the individual practice.
We will also encourage the local lead to take charge in
implementing the intervention with their team.
The intervention given to health care professionals will
be based on the NICE guidelines for obesity, and when
appropriate will draw on other resources such as the
NICE obesity presenter slides, the NICE obesity baseline
assessment tool, Lightening the load: tackling overweight
and obesity [29] and the obesity care pathway and Your
weight, your health [30].
Determinants not addressed by the implementation
intervention
The implementation intervention aims to address a var-
iety of determinants identified in previous work. There
were some determinants which could not be addressed
within this intervention, generally because additional re-
sources would be required. These include:
 Use of health care assistants/receptionists to weigh
patients
 Patients are only weighed as part of their routine
care. Therefore, some patients are not weighed on a
regular basis.
 A trained specialist individual within primary care
who can conduct everything (weighing, advice,
assess motivation, offer referral).
 Local referral policies may restrict the range of
patients who can be referred to specialist care.
 Dietitian run clinic in GP surgery.
 Running a group service at the GP surgery which
provides weekly advice/support.
The teams in the control group will receive no inter-
ventions. After the trial has ended, they will receive feed-
back about their own performance in comparison with
the performance of others in the study, in relation to theguideline recommendations. They will receive no other
interventions.
If the intervention is successful, teams in the control
group will be offered a compact disc containing all the
materials and resources used within the intervention
teams.
Outcomes
Primary outcome
The primary outcome measure relates to recommenda-
tion 3 (Table 1), the proportion of overweight or obese
patients to whom the health professional has offered a
weight loss intervention within the study period. The pa-
tient population is defined as all patients with a BMI
measurement of 25 kg/m2 or higher recorded in their
medical notes at the time of the centre randomisation.
Secondary outcomes
We will collect data from each practice on:
 The proportion of patients with a BMI or waist
circumference measurement recorded within the
study period (recommendation 1);
 the proportion of patients with a record of lifestyle
assessment (recommendation 2);
 referral to external weight loss services
(recommendation 4);
 the proportion of overweight/obese patients who
changed weight (lost or gained 1 kg) during the
study period;
 the mean weight change over the same period.
Measurement procedures
In each general practice, measurements of performance
by participating primary care teams (GPs and practice
nurses) will be performed at baseline and at follow-up
after up to 9 months (the study period).
The following measurement methods will be used: rec-
ord audit for primary and secondary outcome measures,
and interviews and questionnaires for primary care teams
to collect information on the process of the study.
Specific measures will include:
1. Data relating to the primary and secondary outcome
measures will be obtained from the electronic
medical records that are routinely collected in each
general practice. We have developed bespoke data
extraction software for use in a pilot study. This
software will be adapted to ensure capture of all the
relevant data from records. All adults in each
practice are included, and full data protection
procedures will be followed. The software will
identify those patients with a recorded BMI of
25 kg/m2 or over, and the recorded management of
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collected in one data extraction at the end of the
intervention.
2. An interview will be undertaken with a primary care
team member to identify the numbers of registered
patients, patient demography, performance in the
QOF and procedures for managing obesity.
3. To assess the tailoring of the intervention, we will
record notes on the delivery of the implementation
interventions to each team, how it is perceived and
if and how it is adapted. We will also interview a
member of the primary care team to explore their
experiences of the interventions.
4. The practice obesity lead will be asked to complete a
self-report questionnaire to the obesity lead of the
participating primary care team to identify any devi-
ations from the interventions and any adaptations
that were necessary, and why.
Process evaluation
A detailed protocol for a process evaluation has been de-
veloped as is being reported separately [31]. In accord-
ance with this protocol, we aim to examine the fidelity
of the planned intervention strategy and how this relates
to the effectiveness of the implementation programme,
and to identify possible mechanisms underlying effect-
iveness (or lack of it) on primary and secondary
outcomes.
Recruitment
All primary care teams in the East Midlands of England
will be invited to participate in the study. The area in-
cludes the following CCGs: Leicester City CCG, East
Leicester & Rutland CCG, West Leicestershire CCG,
NHS Southern Derbyshire CCG, North Derbyshire
CCG, NHS Lincolnshire East CCG, Lincolnshire West
CCG, North East Lincolnshire CCG, North Lincolnshire
CCG, Mansfield and Ashfield CCG, Nottingham North
& East CCG, Nottingham West CCG, Rushcliffe CCG,
NHS Nottingham City CCG, Newark & Sherwood CCG,
NHS Corby CCG and Nene CCG. Letters of invitation,
with information about the study, will be sent to all the
primary care teams in these CCGs.
Randomisation
Randomisation to the two treatment groups will take
place at the level of the practice team; however, we areTable 4 Study power depending on number of clusters and a
Average cluster size (M) > 1,130 163-212 213-30
Power (1-β) 0.80 0.80 0.81
Number of clusters (N) 12undertaking the primary analysis at the patient level, and
therefore this is a cluster randomised trial.
The randomisation will be stratified by list size (<6000,
≥6000) and deprivation (<20,≥20 practice Index of Mul-
tiple Deprivation scores 2010), where the cut-off points
are related to the median of each of variable of all re-
gions in England [27].
Centres will apply for randomisation sequentially. To
avoid larger imbalances between the four strata (to
mimic the underlying distribution of GP practices in
England), the following restriction will be implemented:
none of the 4 strata shall contain more than 10 prac-
tices, and the maximum of 10 practices is only allowed if
all other strata contain at least 4 practices, otherwise the
maximum should be 8. The randomisation will be per-
formed independently from the trial office by the Leices-
ter Clinical Trials Unit.
Blinding
Participant teams cannot be blinded to whether or not
they are receiving an intervention. Data collection will
use a standard electronic system and, to minimise bias,
all data will be collected using full anonymisation using
a standardized data query.
Statistical methods
Using an intention-to-treat approach, the primary ana-
lyses will use generalised estimating equations that as-
sume the outcome has a binomial distribution, include a
term to account for the practice-level clustering, and use
a logit link function to compare the proportion of over-
weight and obese patients that have been offered a
weight loss intervention between the two arms. The sec-
ondary outcomes will be analysed using similar methods,
with appropriate distributions and link functions se-
lected. Baseline is defined as the last value obtained
within 1 year prior to randomisation. Missing values of
quantitative endpoints will not be imputed.
A detailed Statistical Analysis Plan will be produced
prior to collection of the data and the database lock.
Data collected from electronic records will be trans-
ferred to a statistical package for analysis. A Consoli-
dated Standards of Reporting Trials (CONSORT)
diagram showing the progress of clusters and patients
through phases of the trial will be produced [32]. De-
scriptive characteristics of the centres and their patients
at baseline and follow-up will be summarized by treat-
ment arm, using mean (standard deviation) or medianverage cluster size
9 310-568 569-3,464 > 3,464 > 287
0.82 0.83 0.84 0.85
13 14
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http://www.trialsjournal.com/content/15/1/82(interquartile range) for continuous variables as appro-
priate, and count (percentage) for categorical variables.
Sample size
It is assumed that, in the control arm, the adherence will
be 46%. These estimates are based on a local pilot study of
management of obesity in primary care completed in 2010
to 2011, and were measured at the team level and so are
an approximation [14]. The aim of the study is to detect
an increase to 60% adherence in the intervention arm with
80% power, using a two-sided test with alpha of 0.05. The
intraclass correlation coefficient is assumed to be 0.05.
We determined the number of clusters per treatment
using these values and with various numbers of clusters
and cluster sizes (Table 4) (R-package CRTsize) [33].
As the average number of overweight patients per centre
with baseline data is likely to be larger than about 500, it
was deemed adequate to choose a total sample size of 28
primary care teams, which would allow adequate power
even in the case of a drop out of up to four teams.
Ethics
Research ethical approval was granted from the NRES
Committee London - Camden & Islington (13/LO/1157)
on 18 July 2013.
Discussion
This study is part of a programme of research being
undertaken in five European countries to develop the
methods of tailored implementation [16]. A rigorous
process has been followed to select approaches for iden-
tifying the determinants of practice [22], and a system-
atic procedure was followed to apply methods of
selecting interventions to account for the determinants.
Obesity is a serious problem for health services, and it is
not always identified and managed effectively by primary
care services in England and other countries. Therefore,
in addition to providing evidence about the methods of
tailoring, the study should improve evidence on ap-
proaches to improving the care of obese patients in pri-
mary care.
Trial status
Invitations to participate in the study have been sent to
practices. Randomisation of recruited practices has
commenced.
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